[1]
Moslim Allawi, A. et al. 2025. A prospective study of metformin effectiveness as a mammalian target of rapamycin inhibitor and immunoregulator in women with polycystic ovarian syndrome. Journal of Neonatal Surgery. 14, 1S (Feb. 2025), 608–617. DOI:https://doi.org/10.52783/jns.v14.1585.